News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
MPM ASSET MANAGEMENT LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/24/2023 |
4
| MPM ASSET MANAGEMENT LLC (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Sold 70,170 shares
@ $1.88, valued at
$131.9k
Exercised (in-or-at-the-money) 42,761 warrants
@ $0.74, valued at
$31.6k
Exercised (in-or-at-the-money) 135,508 warrants
@ $0.74, valued at
$100.3k
|
|
| 05/12/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/11/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/13/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/11/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/13/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/13/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 04/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2021 |
4
| MPM BioVentures 2014, L.P. (10% Owner) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Sold 13,006 shares
@ $21.23, valued at
$276.1k
Sold 1,363 shares
@ $21.08, valued at
$28.7k
Sold 706,825 shares
@ $20, valued at
$14.1M
|
|
| 01/22/2021 |
4
| MPM BioVentures 2014, L.P. (10% Owner) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Sold 15,694 shares
@ $23.95, valued at
$375.9k
Sold 2,000 shares
@ $24.71, valued at
$49.4k
Disposed of 101,646 shares
@ $0
Sold 20,979 shares
@ $22.11, valued at
$463.8k
Sold 4,887 shares
@ $22.61, valued at
$110.5k
Sold 200 shares
@ $23.77, valued at
$4.8k
Sold 24,695 shares
@ $21.72, valued at
$536.4k
|
|
| 11/13/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 10/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2020 |
3
| MPM BioVentures 2014, L.P. (10% Owner) has filed a Form 3 on Oncorus, Inc. |
| 08/12/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/13/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/14/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/14/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/29/2019 |
13F-HR/A
| Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend] |
| 05/13/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/21/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2019 |
4
| MPM BioVentures 2014, L.P. (10% Owner) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Converted 1,525,164 shares
@ $0
Converted 1,578,751 shares
@ $0
Converted 417,852 shares
@ $0
Sold 1,524 shares
@ $14, valued at
$21.3k
Bought 250,000 shares
@ $14, valued at
$3.5M
Converted 1,525,164 preferred shares
@ $0
Converted 1,578,751 preferred shares
@ $0
Converted 417,852 preferred shares
@ $0
Exercised (in-or-at-the-money) 25,418 warrants
@ $0.0492, valued at
$1.3k
Exercised (in-or-at-the-money) 57,192 warrants
@ $0.0492, valued at
$2.8k
Exercised (in-or-at-the-money) 171,579 warrants
@ $0.0492, valued at
$8.4k
|
|
| 02/13/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/13/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/07/2019 |
3
| MPM BioVentures 2014, L.P. (10% Owner) has filed a Form 3 on Harpoon Therapeutics, Inc. |
| 11/14/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
|
|
|